Review highlights discoveries of cyanobacterial metabolites, outlining methodologies and biosynthetic pathways relevant to diverse compounds.
Covering: 2021 to 2024This review highlights cyanobacteria secondary metabolites reported between 2021 and 2024. Those compounds are categorised into major classes, including peptides, alkaloids, lipids, polyketides, terpenes/terpenoids, and natural products from other classes. For selected compounds, the review provides details of advanced methodologies employed in their discovery, isolation and structure elucidation. Particular attention is placed on techniques for determining the relative and absolute configurations of stereocentres, including computational approaches, chemical derivatisation, and total synthesis. Furthermore, the review outlines the biosynthetic pathway of several newly identified cyanobacterial natural products.
No takes yet. Share an insight, caveat, or question.
Sieber et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: